跳至主要内容
临床试验/NCT04374981
NCT04374981已完成2 期

Effect of Pineapple Juice on the Pharmacokinetics of Celecoxib and Montelukast in Humans

Damanhour University1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2019年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
24
试验地点
1
主要终点
The terminal elimination half-life (t1/2)

研究概览

简要总结

Pineapple (Ananas comosus) is a tropical fruit that is rich in antioxidents, enzymes and vitamins. It is used worldwide due to their anti-inflammatory and analgesic properties. The effect of pineapple Juice on the Pharmacokinetics of celecoxib and montelukast in Humans was studied.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy subjects (body mass index between 21 to 25 kg/m2).

排除标准

  • Drug abuse.
  • Abnormal level of kidney or liver functions.

研究组 & 干预措施

Celecoxib

Experimental

Twelve healthy male subjects participated in this arm under fasting condition. A randomized, open-label, 2-way crossover study design with 2-week washout period between treatments was used. Participants received a single oral dose of celecoxib tablets (100mg) after pre-treatment with 250ml of either pineapple juice or water (control) for four consecutive days before the beginning of the study.

干预措施: Celecoxib 100mg (Drug)

Montelukast

Experimental

Twelve healthy male subjects participated in this arm under fasting condition. A randomized, open-label, 2-way crossover study design with 2-week washout period between treatments was used. Participants received a single oral dose of Montelukast tablets (10mg) after pre-treatment with 250ml of either pineapple juice or water (control) for four consecutive days before the beginning of the study.

干预措施: Montelukast 10mg (Drug)

结局指标

主要结局

The terminal elimination half-life (t1/2)

时间窗: 12 weeks

The area under the concentration-time curve from zero to infinity (AUC0-∞)

时间窗: 12 weeks

Time to reach plasma peak concentration [Tmax]

时间窗: 12 weeks

Maximum Plasma Concentration [Cmax]

时间窗: 12 weeks

Time to reach maximum plasma concentration [Tmax]

时间窗: 12 weeks

次要结局

  • Clearance (CLT/F)(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sally Helmy, PhD, CPHQ

Associate professor

Damanhour University

研究点 (1)

Loading locations...

相似试验